FR2497510B1 - Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine - Google Patents

Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine

Info

Publication number
FR2497510B1
FR2497510B1 FR8200094A FR8200094A FR2497510B1 FR 2497510 B1 FR2497510 B1 FR 2497510B1 FR 8200094 A FR8200094 A FR 8200094A FR 8200094 A FR8200094 A FR 8200094A FR 2497510 B1 FR2497510 B1 FR 2497510B1
Authority
FR
France
Prior art keywords
butyrobetain
treatment
pharmaceutical composition
composition containing
carnitine deficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8200094A
Other languages
English (en)
Other versions
FR2497510A1 (fr
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of FR2497510A1 publication Critical patent/FR2497510A1/fr
Application granted granted Critical
Publication of FR2497510B1 publication Critical patent/FR2497510B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8200094A 1981-01-06 1982-01-06 Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine Expired FR2497510B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Publications (2)

Publication Number Publication Date
FR2497510A1 FR2497510A1 (fr) 1982-07-09
FR2497510B1 true FR2497510B1 (fr) 1986-04-25

Family

ID=11260827

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8200094A Expired FR2497510B1 (fr) 1981-01-06 1982-01-06 Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine

Country Status (15)

Country Link
US (1) US4382092A (fr)
JP (1) JPS57136516A (fr)
AU (1) AU548787B2 (fr)
BE (1) BE891639A (fr)
CH (1) CH649218A5 (fr)
DE (1) DE3200016A1 (fr)
FR (1) FR2497510B1 (fr)
GB (1) GB2091101B (fr)
GR (1) GR75132B (fr)
IE (1) IE52404B1 (fr)
IL (1) IL64632A0 (fr)
IT (1) IT1198434B (fr)
LU (1) LU83869A1 (fr)
NL (1) NL8200022A (fr)
SE (1) SE453569B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
IT1219448B (it) * 1988-02-12 1990-05-18 Sigma Tau Ind Farmaceuti Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
JP2553013B2 (ja) * 1993-07-19 1996-11-13 ヤマハ発動機株式会社 燃料噴射式エンジンの吸気装置
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
KR100411275B1 (ko) * 1999-09-15 2003-12-18 주식회사 포스코 언로더 코일 적치위치 제어장치
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
GB2091101A (en) 1982-07-28
IE52404B1 (en) 1987-10-14
JPH0424325B2 (fr) 1992-04-24
AU7908781A (en) 1982-07-15
FR2497510A1 (fr) 1982-07-09
SE8200007L (sv) 1982-07-07
LU83869A1 (fr) 1982-05-07
DE3200016A1 (de) 1982-08-12
DE3200016C2 (fr) 1992-12-03
US4382092A (en) 1983-05-03
NL8200022A (nl) 1982-08-02
IE813099L (en) 1982-07-06
BE891639A (fr) 1982-04-16
JPS57136516A (en) 1982-08-23
IT8147518A0 (it) 1981-01-06
SE453569B (sv) 1988-02-15
GB2091101B (en) 1985-02-20
CH649218A5 (it) 1985-05-15
GR75132B (fr) 1984-07-13
IT1198434B (it) 1988-12-21
AU548787B2 (en) 1986-01-02
IL64632A0 (en) 1982-03-31

Similar Documents

Publication Publication Date Title
FR2503562B1 (fr) Conditionnement pharmaceutique pour le traitement des symptomes de menopause
FR2497510B1 (fr) Composition pharmaceutique contenant de la g-butyrobetaine pour le traitement des syndromes provoques par une carence en l-carnitine
BE890648A (fr) Compositions pour le traitement de l'acne
FR2578421B1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
BE891987A (fr) Composition pharmaceutique pour le traitement des maladies de la cavite buccale
FR2532157B1 (fr) Procede de preparation d'une gelee contenant des sarcocarpes
MA20655A1 (fr) Compositions pour le traitement de textiles
PT84697A (fr) Procede pour la preparation de compositions pour le traitement de la calvitie et des alopecies contenant phenytoine et diazoxyde
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
IT8223309A0 (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
PT77428A (fr) Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
FR2588756B1 (fr) Composition pour le traitement des cheveux
FR2515516B1 (fr) Composition pharmaceutique pour le traitement de la lithiase renale infectee contenant de l'acide propionohydroxamique ou ses sels acceptables en pharmacie
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
FR2536280B1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
BE892781A (fr) Nouvelles compositions pharmaceutiques pour le traitement du diabete
FR2517203B1 (fr) Composition pour le traitement de l'acne
FR2562798B1 (fr) Agent pharmaceutique pour le traitement du psoriasis
RO86562A2 (fr) Composition vegetale medicamenteuse pour le traitement des affectionsbiliares

Legal Events

Date Code Title Description
ST Notification of lapse